GIOSTAR Announces FDA Approval Under Compassionate Use for a COVID-19 with Stem Cells

March 22, 2023

Treatment of COVID-19 patients with mesenchymal stem cells (MSCs) has been shown to be beneficial in a number of studies from USA, Israel, China and UAE[Admin1] . In the U.S., the FDA approved a clinical trial to study use of umbilical cord stem cells in the treatment of COVID-19 patients https://newsroom.baptisthealth.net/press-release/fda-approves-covid-19-trial-after-successful-emergency-use-of-umbilical-stem-cells-from-restem/

Posted in

Recent Blog

GIOSTAR: The Shining Star of Modern Healthcare Industry & BioTech
March 28, 2023
Giostar has agreed to commercialize and promote dcgi (Indian FDA) approved stem cell therapies for critical lab ischemia and osteoarthritis
March 28, 2023
Dr. Anand Srivastava, GIOSTAR Co-Founder: How Does Cell Therapy Work?
March 28, 2023

Latest News

Honourable Speaker DR Anand Srivastava at 1ST INTERNATIONAL CONFERENCE ON MEDICINE AND RESEARCH (ICMR-21)
March 28, 2023
Health Talk on Metabolic Diseases Can Be Cured by Stem Cell Therapy at USTM, Guwahati on Dec 18, 2021, by DR. Anand Srivastava Chairman GIOSTAR- USA.
March 28, 2023
SAASCR honours GIOSTAR chairman DR. Anand & 9 Indian American Scientists for their Outstanding Cancer Researching
March 28, 2023

Videos

Meet Dr. Anand Srivastava
March 29, 2023
Dr Anand Srivastava of GIOSTAR Discusses How Stem Cells and Regenerative Therapy Treat Diabetes
March 29, 2023
What is Stem Cell Therapy? by Dr. Anand Srivastava | 40th Vikram Sarabhai Memorial Lecture | GIOSTAR
March 29, 2023